- Wondering if Colgate-Palmolive at around US$85.50 is offering fair value, or if you might be paying up for a quality brand name.
- The stock is up 10.1% year to date, even after a 2.8% slip over the last week and a 10.6% pullback over the past month. The 1-year return sits at a 3.0% decline and the 3- and 5-year returns are 27.8% and 23.6% respectively.
- These mixed returns often prompt investors to reassess what they are really paying for, especially when a consumer staple name like Colgate-Palmolive sees shorter-term weakness alongside longer-term gains. That context makes valuation tools particularly useful for judging whether recent pricing reflects changing risk perceptions or simply normal share price swings.
- On Simply Wall St's 6-point valuation checklist, Colgate-Palmolive scores 2 out of 6. Next up is a look at how different valuation methods frame that score, and why there may be an even richer way to think about value by the end of this article.
Colgate-Palmolive scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
Approach 1: Colgate-Palmolive Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model estimates what a business might be worth by projecting its future cash flows and then discounting those back to today’s dollars. It is essentially asking what the stream of future cash that Colgate-Palmolive could generate is worth right now.
For Colgate-Palmolive, the model uses a 2 Stage Free Cash Flow to Equity approach built on cash flow projections. The latest twelve month free cash flow stands at about $3.58b. Analyst estimates and subsequent extrapolations suggest free cash flow of about $4.10b in 2030, with intermediate projections between 2026 and 2035 ranging from roughly $3.29b to $4.88b, all in $ and then discounted back to today.
Putting those cash flows together, Simply Wall St’s DCF output points to an intrinsic value of about $125.40 per share. Against a current share price around $85.50, that implies the stock is 31.8% below this DCF estimate, which the model interprets as undervalued on these assumptions.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Colgate-Palmolive is undervalued by 31.8%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.
Approach 2: Colgate-Palmolive Price vs Earnings
For a profitable company like Colgate-Palmolive, the P/E ratio is a straightforward way to connect what you pay for the stock with the earnings the business is generating today. Investors typically accept a higher P/E when they expect stronger earnings growth or see lower risk, and a lower P/E when growth looks slower or risks appear higher.
Colgate-Palmolive currently trades on a P/E of 32.14x. That sits above the Household Products industry average P/E of 16.36x and the broader peer group average of 22.12x, suggesting investors are currently paying a higher price for each dollar of earnings compared with many peers.
Simply Wall St’s Fair Ratio for Colgate-Palmolive is 27.86x. This is a proprietary estimate of what a more tailored P/E could look like after considering factors such as the company’s earnings growth profile, profit margins, industry, market cap and specific risks. Because it adjusts for these features, the Fair Ratio aims to be more informative than a simple comparison with industry or peer averages.
Set against the current P/E of 32.14x, the Fair Ratio of 27.86x points to Colgate-Palmolive trading somewhat above this tailored estimate.
Result: OVERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your Colgate-Palmolive Narrative
Earlier it was mentioned that there is an even better way to understand valuation. Narratives are introduced here as a simple way for you to attach a clear story about Colgate-Palmolive to your own numbers, link that story to a revenue, earnings and margin forecast, and then compare your fair value to the current price using an easy tool on Simply Wall St's Community page that updates automatically when fresh news or earnings arrive. For example, one Colgate-Palmolive Narrative might lean toward the higher US$106 price target by focusing on the 2030 plan, emerging markets exposure and cost programs. Another might sit closer to the US$83 price target by putting more weight on consumer caution, cost pressures and competitive risks. This gives you a structured way to see which story you agree with and what that implies for your next move.
Do you think there's more to the story for Colgate-Palmolive? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com